Early diagnosis of Sickle Cell Disease (SCD) remains one of the most important management strategies for the disease. Certain complications can be prevented and treated with early diagnosis. Post natal screening for SCD and other genetic diseases is the standard for most developed nations, which means SCD diagnosis usually comes earlier in life. Diagnosis remains a challenge in most underdeveloped nations where the available health care infrastructure and services often do not have the capacity for such screening. The development of a quick and inexpensive tests for SCD is hence a priority. According to Science Daily, Havard Post-Doctoral fellow A.J. Kumar and his colleagues at the lab of George Whitesides, the Woodford L. and Ann A. Flowers University Professor, have developed a new test for SCD capable of providing results in just 12 minutes. The test which costs as little as 50 cents is currently the fastest and least expensive test for SCD available. Read more about the test and its techniques here.
Other developments this week:
Blood and marrow transplantation for sickle cell disease: Is less more?
Hydroxyurea and Growth in Young Children With Sickle Cell Disease
Phytomedicines of sickle cell crisis in Mezam Division, Cameroon: preventive and curative cares
Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks.
The Effectiveness of Self-Management Programs on Self-Efficacy in Patients With Sickle Cell Disease
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
Evaluating the knowledge of sickle cell disease and hemoglobin electrophoretic pattern among people living in Sekondi-Takoradi Metropolis, Ghana
Sickle Cell Trait and Incident Ischemic Stroke in the Atherosclerosis Risk in Communities Study
Abnormalities in renal tubular phosphate handling in children with sickle cell disease
Acute Chest Syndrome
Sickle Cell Disease Management
Have a great weekend!
The ASN Team.
No comments:
Post a Comment